Interlaboratory proficiency processing scheme in CSF aliquoting: implementation and assessment based on biomarkers of Alzheimer’s disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-9193
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Interlaboratory proficiency processing scheme in CSF aliquoting: implementation and assessment based on biomarkers of Alzheimer’s disease ; volume:10 ; number:1 ; day:28 ; month:8 ; year:2018 ; pages:1-9 ; date:12.2018
Alzheimer's research & therapy ; 10, Heft 1 (28.8.2018), 1-9, 12.2018
- Creator
- Contributor
-
Gaignaux, Amélie
Kofanova, Olga
Ermann, Natalia
Betsou, Fay
Brandner, Sebastian
Mroczko, Barbara
Blennow, Kaj
Strapagiel, Dominik
Paciotti, Silvia
Vogelgsang, Jonathan
Roehrl, Michael H.
Mendoza, Sandra
Kornhuber, Johannes
Teunissen, Charlotte
SpringerLink (Online service)
- DOI
-
10.1186/s13195-018-0418-3
- URN
-
urn:nbn:de:101:1-2018102000082903123595
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:20 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lewczuk, Piotr
- Gaignaux, Amélie
- Kofanova, Olga
- Ermann, Natalia
- Betsou, Fay
- Brandner, Sebastian
- Mroczko, Barbara
- Blennow, Kaj
- Strapagiel, Dominik
- Paciotti, Silvia
- Vogelgsang, Jonathan
- Roehrl, Michael H.
- Mendoza, Sandra
- Kornhuber, Johannes
- Teunissen, Charlotte
- SpringerLink (Online service)
Other Objects (12)
Interlaboratory proficiency processing scheme in CSF aliquoting: implementation and assessment based on biomarkers of Alzheimer’s disease
A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood
Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Der N-Methyl-D-Aspartat (NMDA)-Rezeptor im menschlichen Gehirn : experimentelle Studien unter besonderer Berücksichtigung der Schizophrenien
Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer’s disease pathology and clinical disease progression
Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
Fluid biomarkers in Alzheimer’s disease – current concepts
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease
Diversitätsintelligenz
Interlaboratory proficiency processing scheme in CSF aliquoting: implementation and assessment based on biomarkers of Alzheimer’s disease
A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood
Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Der N-Methyl-D-Aspartat (NMDA)-Rezeptor im menschlichen Gehirn : experimentelle Studien unter besonderer Berücksichtigung der Schizophrenien
Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer’s disease pathology and clinical disease progression
Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
Fluid biomarkers in Alzheimer’s disease – current concepts
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease
Diversitätsintelligenz
Interlaboratory proficiency processing scheme in CSF aliquoting: implementation and assessment based on biomarkers of Alzheimer’s disease
A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood
Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Der N-Methyl-D-Aspartat (NMDA)-Rezeptor im menschlichen Gehirn : experimentelle Studien unter besonderer Berücksichtigung der Schizophrenien
Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer’s disease pathology and clinical disease progression
Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
Fluid biomarkers in Alzheimer’s disease – current concepts
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease